Trials / Completed
CompletedNCT02158689
Comparison of Treatment Modalities in Poor Responders Undergoing IVF
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Ercan Bastu · Academic / Other
- Sex
- Female
- Age
- 18 Years – 42 Years
- Healthy volunteers
- Not accepted
Summary
The accurate identification and efficient management of poor responders remains one of the most enigmatic challenges in assisted reproductive technology (ART). The investigators study will compare the letrozole/antagonist protocol to the hMG/antagonist protocol in women who poor responders.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Letrozole | |
| DRUG | human menopausal gonadotropin (hMG) |
Timeline
- Start date
- 2014-06-01
- Primary completion
- 2015-08-01
- Completion
- 2015-08-01
- First posted
- 2014-06-09
- Last updated
- 2016-01-08
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02158689. Inclusion in this directory is not an endorsement.